Short-term cellular effects induced by castration therapy in relation to clinical outcome in prostate cancer.

This publication has 25 references indexed in Scilit:

• Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
  1996
• Castration therapy rapidly induces apoptosis in a minority and decreases cell proliferation in a majority of human prostatic tumors.
  1995
• Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
  1994
• Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma
  European Journal Of Cancer, 1994
• SERUM PSA AFTER ANTIANDROGEN THERAPY
  Urologic Clinics of North America, 1993
• Castration‐induced changes in morphology, androgen levels, and proliferative activity of human prostate cancer tissue grown in athymic nude mice
  The Prostate, 1993
• Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the dunning R3327 rat prostatic adenocarcinoma
  The Prostate, 1989
• Activation of Programmed Cell Death in the Rat Ventral Prostate after Castration*
  Endocrinology, 1988
• Therapy of prostatic cancer and histopathologic follow‐up
  The Prostate, 1982
• Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics
  British Journal of Cancer, 1972